Honest Criticisms and Limitations of the KEEPS Trial
A deep-dive into the enrollment biases, follow-up gaps, statistical caveats, and generalizability concerns that limit interpretation of the KEEPS hormone therapy trial.
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.

Showing 8 of 8 clinical reviews.
A deep-dive into the enrollment biases, follow-up gaps, statistical caveats, and generalizability concerns that limit interpretation of the KEEPS hormone therapy trial.
A deep-dive into the KEEPS trial design, randomization, blinding, endpoint definitions, and statistical choices that shape how early HRT timing results should be interpreted.
A clinical deep-dive into cost-effectiveness analyses derived from the KEEPS trial, covering cost per QALY estimates, list-price vs net-price realities for menopausal hormone therapy, and how payer coverage decisions interact with the timing hypothesis.
What the KEEPS trial follow-up revealed about long-term HRT safety, durability of cardiovascular and cognitive outcomes, and the timing hypothesis in early menopause.
A detailed breakdown of the KEEPS trial results, including CIMT effect sizes, confidence intervals, coronary calcium scores, secondary endpoints, subgroup analyses, and time-course patterns for oral CEE and transdermal estradiol in early menopause.
Detailed breakdown of KEEPS trial pre-specified and post-hoc subgroup analyses examining which early postmenopausal women benefited most from oral CEE or transdermal estradiol on carotid IMT, mood, cognition, and cardiometabolic markers.
An honest, in-depth walkthrough of the Kronos Early Estrogen Prevention Study (KEEPS), what it measured, what it found about HRT and heart health in early menopause, and what those results mean for women today.
A deep-dive into the KEEPS trial's real-world clinical implications for early postmenopausal HRT prescribing, guideline updates, and patient selection beyond the original study population.